MAPT Gene Dementia Frontotemporal NGS Genetic DNA Test
Comprehensive Genetic Testing for Frontotemporal Dementia Risk Assessment
The MAPT Gene Dementia Frontotemporal NGS Genetic DNA Test represents a breakthrough in neurological genetic testing, providing individuals and families with critical insights into their risk for developing frontotemporal dementia (FTD). This advanced diagnostic tool utilizes state-of-the-art Next-Generation Sequencing technology to analyze the MAPT (microtubule-associated protein tau) gene, which plays a fundamental role in maintaining neuronal structure and function.
What Does This Test Measure and Detect?
Our comprehensive NGS genetic test specifically targets the MAPT gene located on chromosome 17, analyzing it for mutations and variations associated with frontotemporal dementia. The test detects:
- Pathogenic mutations in the MAPT gene coding regions
- Single nucleotide polymorphisms (SNPs) linked to FTD risk
- Copy number variations affecting tau protein production
- Genetic markers associated with tauopathies and neurodegenerative disorders
- Inheritance patterns that may affect multiple family generations
Who Should Consider This Genetic Test?
This test is particularly recommended for individuals experiencing or concerned about:
- Progressive changes in personality, behavior, or social conduct
- Language difficulties including speech production or comprehension problems
- Executive function decline affecting planning and decision-making
- Family history of frontotemporal dementia or early-onset dementia
- Unexplained neurological symptoms in individuals under age 65
- Multiple family members affected by similar neurological conditions
- Personal concerns about genetic predisposition to neurodegenerative diseases
Key Benefits of MAPT Gene Testing
Undergoing genetic testing for MAPT gene mutations provides numerous advantages:
- Early Risk Assessment: Identify genetic predisposition before symptom onset
- Family Planning Guidance: Make informed decisions about family genetic risks
- Personalized Monitoring: Enable targeted neurological surveillance and early intervention
- Treatment Planning: Facilitate discussions about future care options and clinical trials
- Psychological Preparation: Reduce uncertainty and anxiety through knowledge
- Research Contribution: Support ongoing neurological genetics research
Understanding Your Test Results
Our genetic counseling team provides comprehensive support in interpreting your MAPT gene test results:
- Positive Result: Indicates the presence of a MAPT gene mutation associated with increased FTD risk. Our genetic counselors will discuss implications, monitoring recommendations, and family testing options.
- Negative Result: No known pathogenic MAPT mutations detected. This may reduce but not eliminate FTD risk, as other genetic and environmental factors may contribute.
- Variant of Uncertain Significance: Some genetic changes require additional research to determine clinical significance. We provide ongoing updates as new information becomes available.
- Carrier Status: Information about inheritance patterns and family member risks.
Test Details and Pricing
| Test Component | Details |
|---|---|
| Test Name | MAPT Gene Dementia Frontotemporal NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) Technology |
| Specialty | Neurology & Genetics |
Pre-Test Requirements
To ensure accurate results and proper interpretation, we require:
- Complete clinical history of the patient undergoing testing
- Genetic counseling session to create a detailed family pedigree chart
- Documentation of family members affected by MAPT gene dementia or frontotemporal disorders
- Informed consent understanding the implications of genetic testing
Nationwide Accessibility
We have testing facilities conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified collection centers ensures easy access to testing services regardless of your location.
Take Control of Your Neurological Health Today
Don’t let uncertainty about your genetic risk for frontotemporal dementia control your future. Our MAPT Gene Dementia Frontotemporal NGS Genetic DNA Test provides the clarity and information you need to make informed healthcare decisions. With our discounted price of $500 USD and comprehensive genetic counseling support, you can take proactive steps toward understanding your neurological health.
Ready to schedule your test? Call or WhatsApp us today at +1(267) 388-9828 to book your appointment or speak with our genetic counseling team. Take the first step toward genetic clarity and peace of mind.
